B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 4.12 PLN 0.49% Market Closed
Market Cap: 353.7m PLN

Operating Margin
Bioton SA

-1.9%
Current
6%
Average
-5.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.9%
=
Operating Profit
-4.4m
/
Revenue
235.9m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
PL
Bioton SA
WSE:BIO
353.8m PLN
-2%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
336.1B USD
30%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
-2 834%
US
Amgen Inc
NASDAQ:AMGN
164.8B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
144.7B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
129.7B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.9B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%

Bioton SA
Glance View

Market Cap
353.8m PLN
Industry
Biotechnology

BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

BIO Intrinsic Value
4.19 PLN
Undervaluation 2%
Intrinsic Value
Price
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.9%
=
Operating Profit
-4.4m
/
Revenue
235.9m
What is the Operating Margin of Bioton SA?

Based on Bioton SA's most recent financial statements, the company has Operating Margin of -1.9%.

Back to Top